Pharma Collaboration for Transparent Medical Information (phactMI) Benchmark Study: Trends,Drivers,Success Factors,and Value of Globalization in Medical Information

Abstract

Background:

Over the past decade, biopharmaceutical companies have been progressively establishing global frameworks across their capabilities. It is well recognized that the Medical Information (MI) department is a key externally facing function that needs to maintain a consistent focus on optimizing its capabilities of addressing product medical inquiries worldwide.

Methods:

In the United States, a consortium named Pharma Collaboration for Transparent Medical Information, phactMI, a collaboration of pharmaceutical company MI departments dedicated to supporting health care professionals in their commitment to provide quality patient care, has provided a forum to benchmark and share best practices across the companies. In May 2017, phactMI conducted a survey inclusive of 25 biopharmaceutical companies to gain insight into the globalization of respective MI departments and relevant trends.

Results:

We found increased trends in various aspects of globalization across large, mid, and small size companies, and identified key drivers for success. Overall, 16 of the 25 companies had globalized their MI department, 5 had only partially globalized, and the remaining 4 had not globalized.

Conclusion:

The findings of this survey will further help inform the MI community as to globalization approaches for a successful outcome.

Keywords

medical information globalization benchmark study technology call centers

Get full access to this article

View all access options for this article.

References

Wolf

. Shaping globalization. Finance Devel. 2014;51(3):22–25

James

Steger

. A genealogy of “globalization”: The career of a concept. Globalizations. 2014;11(4):417–434.

Ghemawat

. Globalization in the age of Trump. Harvard Bus Rev. 2017;95(4):112–123.

Valverde

Monnet

Pisani

. The globalization of the pharmaceutical industry. 2016. https://www.ifpma.org/wp-content/uploads/2016/11/The-Globalisation-of-the-Pharmaceutical-Industry-Monograph.pdf. Accessed July 14, 17.

Scholte

. Defining globalisation. World Econ. 2008;31(11):1471–1502.

Challenges Related to Globalization for the Pharmaceutical Industry. United States Department of Commerce website. http://ita.doc.gov/td/health/2010austin_gren.pdf Accessed September 15, 2017.

TranCelerate Biopharma website. http://www.transceleratebiopharmainc.com/. Accessed September 21, 2017.

Ehrlich

Perry

Gelmont

Farhood

. The emerging role of global medical affairs in the twenty-first century. In: Bertolini

Goss

Curling

, eds. Production of Plasma Proteins for Therapeutic Use. 1st ed. New York: John Wiley

phactMI: Pharma Collaboration for Transparent Medical Information website. https://www.phactmi.org/PortalAboutUs. Accessed September 22, 2017.

10.

Riggins

Ferguson

Miller

. Globalizing medical information services at Eli Lilly and company. Drug Inf J. 1999;33:515–524.

11.

Riggins

. Establishing global medical information services: practices and pitfalls. Drug Inf J. 2000;34:1077–1080.

12.

Giffin

Baumeister

Bowers

. Review of the evolution of medical information in light of changes in the external landscape [published online October 30, 2014]. Therapeutic Innovation and Regulatory Science. 2014;48(6):NP6–NP14.

13.

Uma

. A study on training importance for employees of their successful performance in the organization. Int J Sci Res (IJSR). 2013;2:137–140.

14.

Govil

Kumar

. The importance of training in an organization. Adv Manage. 2014;7:44–46.

15.

Pellegrino

McNaughton

. Beyond learning by experience: The use of alternative learning processes by incrementally and rapidly internationalizing SMEs. Int Business Rev. 2017;26:614–627.

16.

Neeley

. Global teams that work. Harv Business Rev. 2015;93:74–78.